Form 4: Amphastar Pharmaceuticals CFO William J. Peters Reports Stock Disposals to Cover Tax Obligations
SEC Filing
William J. Peters, CFO, EVP & Treasurer of Amphastar Pharmaceuticals, reported the disposal of common stock to cover tax liabilities related to the vesting of restricted stock units.
Summary
- William J. Peters, the CFO, EVP, and Treasurer of Amphastar Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
- The transactions involved the disposal of common stock to satisfy tax liabilities associated with the vesting of restricted stock units (RSUs).
- Specifically, 2,285 shares were disposed of on March 15, 2024, 5,105 shares on March 16, 2024, and 4,255 shares on March 17, 2024, all at a price of $43.05.
- Following these transactions, Peters directly owns 97,655 shares of Amphastar Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document reflects a neutral sentiment as it reports routine stock disposals for tax purposes, which is a normal part of executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Disposal of 2,285 common stock shares. |
| 03/16/2024 | Disposal of 5,105 common stock shares. |
| 03/17/2024 | Disposal of 4,255 common stock shares. |
| 03/19/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.